Hjem › Kronisk lymfatisk leukæmi › Californien › Mountain View
Kronisk lymfatisk leukæmi kliniske forsøg i Mountain View, CA
7 studier for Kronisk lymfatisk leukæmi søger deltagere på steder i og omkring Mountain View (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RekruttererFase 3
- Stanford Cancer Institute, Palo Alto · 5 mi væk
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruttererFase 1/2
- Stanford Medicine, Palo Alto · 5 mi væk
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
RekruttererFase 3
- Stanford Cancer Institute, Palo Alto · 5 mi væk
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekruttererFase 3
- Stanford Cancer Institute, Palo Alto · 5 mi væk
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RekruttererFase 3
- Stanford School of Medicine-Cancer Clinical Trials Office, Palo Alto · 5 mi væk
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RekruttererFase 2
- Palo Alto Medical Foundation Research Institute (PAMFRI), Palo Alto · 5 mi væk
- Stanford Cancer Center, Palo Alto · 5 mi væk
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekruttererFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi væk
Kronisk lymfatisk leukæmi forsøg i andre byer
- Boston, MA31 studier
- Columbus, OH28 studier
- Durham, NC27 studier
- Washington, DC22 studier
- Seattle, WA20 studier
- Rochester, MN19 studier
- New York City, NY18 studier
- Houston, TX17 studier
- Baldwin Park, CA16 studier
- Milwaukee, WI15 studier
- Cincinnati, OH14 studier
- Chicago, IL14 studier
Andre studier i Mountain View
- Kræft (alle typer)40 studier
- Brystkræft25 studier
- Metastatisk cancer25 studier
- Ikke-småcellet lungecancer21 studier
- Akut myeloid leukæmi19 studier
- Ægstockræft19 studier
- Autismespektrumforstyrrelse17 studier
- Lungecancer17 studier
- Hjertesvigt15 studier
- Prostatakræft15 studier
- Autisme13 studier
- Akut lymfoblastisk leukæmi13 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.